{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:38:20Z","timestamp":1778787500114,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human infection with the protozoan parasite <jats:italic>Trypanosoma cruzi<\/jats:italic> causes Chagas disease for which there are no prophylactic vaccines. Cyclophilin 19 is a secreted cis-trans peptidyl isomerase expressed in all life stages of <jats:italic>Trypanosoma cruzi<\/jats:italic>. This protein in the insect stage leads to the inactivation of insect anti-parasitic peptides and parasite transformation whereas in the intracellular amastigotes it participates in generating ROS promoting the growth of parasites. We have generated a parasite mutant with depleted expression of Cyp19 by removal of 2 of 3 genes encoding this protein using double allelic homologous recombination. The mutant parasite line failed to replicate when inoculated into host cells in vitro or in mice indicating that Cyp19 is critical for infectivity. The mutant parasite line also fails to replicate in or cause clinical disease in immuno-deficient mice further validating their lack of virulence. Repeated inoculation of mutant parasites into immuno-competent mice elicits parasite-specific trypanolytic antibodies and a Th-1 biased immune response and challenge of mutant immunized mice with virulent wild-type parasites is 100% effective at preventing death from acute disease. These results suggest that parasite Cyp19 may be candidate for small molecule drug targeting and that the mutant parasite line may warrant further immunization studies for prevention of Chagas disease.<\/jats:p>","DOI":"10.1038\/s41541-023-00647-5","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T11:16:07Z","timestamp":1682421367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunization with a Trypanosoma cruzi cyclophilin-19 deletion mutant protects against acute Chagas disease in mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Bijay Kumar","family":"Jha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Varikuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitenya","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2078-7125","authenticated-orcid":false,"given":"Rahul","family":"Shivahare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3383-0249","authenticated-orcid":false,"given":"Gregory P.","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelyn","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakash","family":"Sur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Myler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Schenkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5989-1520","authenticated-orcid":false,"given":"Abhay R.","family":"Satoskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9646-5931","authenticated-orcid":false,"given":"Bradford S.","family":"McGwire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"647_CR1","first-page":"276","volume":"45","author":"A Moncayo","year":"1992","unstructured":"Moncayo, A. Chagas disease: epidemiology and prospects for interruption of transmission in the Americas. World Health Stat. Q 45, 276\u2013279 (1992).","journal-title":"World Health Stat. Q"},{"key":"647_CR2","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/nature09220","volume":"465","author":"J Clayton","year":"2010","unstructured":"Clayton, J. Chagas disease 101. Nature 465, S4\u2013S5 (2010).","journal-title":"Nature"},{"key":"647_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1128\/CMR.00005-11","volume":"24","author":"C Bern","year":"2011","unstructured":"Bern, C., Kjos, S., Yabsley, M. J. & Montgomery, S. P. Trypanosoma cruzi and Chagas\u2019 disease in the United States. Clin. Microbiol. Rev. 24, 655\u2013681 (2011).","journal-title":"Clin. Microbiol. Rev."},{"key":"647_CR4","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1371\/journal.pmed.0040332","volume":"4","author":"RL Tarleton","year":"2007","unstructured":"Tarleton, R. L., Reithinger, R., Urbina, J. A., Kitron, U. & Gurtler, R. E. The challenges of Chagas disease\u2013grim outlook or glimmer of hope. PLoS Med. 4, e332 (2007).","journal-title":"PLoS Med."},{"key":"647_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0020-7519(01)00153-9","volume":"31","author":"KM Tyler","year":"2001","unstructured":"Tyler, K. M. & Engman, D. M. The life cycle of Trypanosoma cruzi revisited. Int. J. Parasitol. 31, 472\u2013481 (2001).","journal-title":"Int. J. Parasitol."},{"key":"647_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/cid\/cir956","volume":"54","author":"MA Shikanai-Yasuda","year":"2012","unstructured":"Shikanai-Yasuda, M. A. & Carvalho, N. B. Oral transmission of Chagas disease. Clin. Infect. Dis. 54, 845\u2013852 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"647_CR7","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1128\/JCM.00048-10","volume":"48","author":"MI Jercic","year":"2010","unstructured":"Jercic, M. I., Mercado, R. & Villarroel, R. Congenital Trypanosoma cruzi infection in neonates and infants from two regions of Chile where Chagas\u2019 disease is endemic. J. Clin. Microbiol. 48, 3824\u20133826 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"647_CR8","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3389\/fmicb.2019.01854","volume":"10","author":"U Kemmerling","year":"2019","unstructured":"Kemmerling, U., Osuna, A., Schijman, A. G. & Truyens, C. Congenital transmission of Trypanosoma cruzi: a review about the interactions between the parasite, the placenta, the maternal and the fetal\/neonatal immune responses. Front. Microbiol. 10, 1854 (2019).","journal-title":"Front. Microbiol."},{"key":"647_CR9","doi-asserted-by":"publisher","first-page":"e0005507","DOI":"10.1371\/journal.pntd.0005507","volume":"11","author":"D Silva-Dos-Santos","year":"2017","unstructured":"Silva-Dos-Santos, D. et al. Unraveling Chagas disease transmission through the oral route: gateways to Trypanosoma cruzi infection and target tissues. PLoS Negl. Trop. Dis. 11, e0005507 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"647_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","volume":"1","author":"A Prata","year":"2001","unstructured":"Prata, A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1, 92\u2013100 (2001).","journal-title":"Lancet Infect. Dis."},{"key":"647_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1128\/CMR.00063-10","volume":"24","author":"AR Teixeira","year":"2011","unstructured":"Teixeira, A. R., Hecht, M. M., Guimaro, M. C., Sousa, A. O. & Nitz, N. Pathogenesis of chagas\u2019 disease: parasite persistence and autoimmunity. Clin. Microbiol. Rev. 24, 592\u2013630 (2011).","journal-title":"Clin. Microbiol. Rev."},{"key":"647_CR12","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.4269\/ajtmh.16-0213","volume":"95","author":"SP Montgomery","year":"2016","unstructured":"Montgomery, S. P., Parise, M. E., Dotson, E. M. & Bialek, S. R. What do we know about Chagas disease in the United States. Am. J. Trop. Med. Hyg. 95, 1225\u20131227 (2016).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"647_CR13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1590\/S1807-59322009001200013","volume":"64","author":"NM Matsuda","year":"2009","unstructured":"Matsuda, N. M., Miller, S. M. & Evora, P. R. The chronic gastrointestinal manifestations of Chagas disease. Clinics 64, 1219\u20131224 (2009).","journal-title":"Clinics"},{"key":"647_CR14","first-page":"659","volume":"6","author":"MS Cardoso","year":"2015","unstructured":"Cardoso, M. S., Reis-Cunha, J. L. & Bartholomeu, D. C. Evasion of the immune response by Trypanosoma cruzi during acute infection. Front. Immunol. 6, 659 (2015).","journal-title":"Front. Immunol."},{"key":"647_CR15","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.4049\/jimmunol.166.7.4596","volume":"166","author":"S Kumar","year":"2001","unstructured":"Kumar, S. & Tarleton, R. L. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. J. Immunol. 166, 4596\u20134603 (2001).","journal-title":"J. Immunol."},{"key":"647_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1128\/IAI.68.1.197-204.2000","volume":"68","author":"DF Hoft","year":"2000","unstructured":"Hoft, D. F., Schnapp, A. R., Eickhoff, C. S. & Roodman, S. T. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect. Immun. 68, 197\u2013204 (2000).","journal-title":"Infect. Immun."},{"key":"647_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/cimm.1996.0132","volume":"170","author":"LC Barbosa de Oliveira","year":"1996","unstructured":"Barbosa de Oliveira, L. C., Curotto de Lafaille, M. A., Collet de Araujo Lima, G. M. & de Almeida Abrahamsohn, I. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection. Cell Immunol. 170, 41\u201353 (1996).","journal-title":"Cell Immunol."},{"key":"647_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5493\/wjem.v3.i1.1","volume":"3","author":"B Basso","year":"2013","unstructured":"Basso, B. Modulation of immune response in experimental Chagas disease. World J. Exp. Med. 3, 1\u201310 (2013).","journal-title":"World J. Exp. Med."},{"key":"647_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.coi.2009.07.006","volume":"21","author":"AM Padilla","year":"2009","unstructured":"Padilla, A. M., Bustamante, J. M. & Tarleton, R. L. CD8+ T cells in Trypanosoma cruzi infection. Curr. Opin. Immunol. 21, 385\u2013390 (2009).","journal-title":"Curr. Opin. Immunol."},{"key":"647_CR20","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1128\/IAI.73.9.6017-6025.2005","volume":"73","author":"AF Araujo","year":"2005","unstructured":"Araujo, A. F. et al. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2. Infect. Immun. 73, 6017\u20136025 (2005).","journal-title":"Infect. Immun."},{"key":"647_CR21","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/IAI.00278-09","volume":"78","author":"OK Giddings","year":"2010","unstructured":"Giddings, O. K., Eickhoff, C. S., Sullivan, N. L. & Hoft, D. F. Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges. Infect. Immun. 78, 1333\u20131338 (2010).","journal-title":"Infect. Immun."},{"key":"647_CR22","doi-asserted-by":"publisher","first-page":"e1004828","DOI":"10.1371\/journal.ppat.1004828","volume":"11","author":"S Gupta","year":"2015","unstructured":"Gupta, S. & Garg, N. J. A two-component DNA-prime\/protein-boost vaccination strategy for eliciting long-term, protective T cell immunity against Trypanosoma cruzi. PLoS Pathog. 11, e1004828 (2015).","journal-title":"PLoS Pathog."},{"key":"647_CR23","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1128\/IAI.70.10.5547-5555.2002","volume":"70","author":"N Garg","year":"2002","unstructured":"Garg, N. & Tarleton, R. L. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect. Immun. 70, 5547\u20135555 (2002).","journal-title":"Infect. Immun."},{"key":"647_CR24","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.3389\/fimmu.2019.02698","volume":"10","author":"L Michel-Todo","year":"2019","unstructured":"Michel-Todo, L. et al. In silico design of an epitope-based vaccine ensemble for Chagas disease. Front. Immunol. 10, 2698 (2019).","journal-title":"Front. Immunol."},{"key":"647_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/v8030078","volume":"8","author":"AL Farrow","year":"2016","unstructured":"Farrow, A. L., Peng, B. J., Gu, L., Krendelchtchikov, A. & Matthews, Q. L. A novel vaccine approach for Chagas disease using rare adenovirus serotype 48 vectors. Viruses 8, 78 (2016).","journal-title":"Viruses"},{"key":"647_CR26","doi-asserted-by":"publisher","first-page":"e1004594","DOI":"10.1371\/journal.ppat.1004594","volume":"11","author":"IR Pereira","year":"2015","unstructured":"Pereira, I. R. et al. A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy. PLoS Pathog. 11, e1004594 (2015).","journal-title":"PLoS Pathog."},{"key":"647_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1128\/IAI.01163-07","volume":"76","author":"SI Cazorla","year":"2008","unstructured":"Cazorla, S. I. et al. Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi. Infect. Immun. 76, 324\u2013333 (2008).","journal-title":"Infect. Immun."},{"key":"647_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1590\/0074-02760160019","volume":"111","author":"B Basso","year":"2016","unstructured":"Basso, B., Marini, V., Gauna, D. & Frias, M. Vaccination of dogs with Trypanosoma rangeli induces antibodies against Trypanosoma cruzi in a rural area of Cordoba, Argentina. Mem. Inst. Oswaldo Cruz 111, 271\u2013274 (2016).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"647_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/icb.1984.14","volume":"62","author":"GF Mitchell","year":"1984","unstructured":"Mitchell, G. F., Handman, E. & Spithill, T. W. Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection. Aust. J. Exp. Biol. Med. Sci. 62, 145\u2013153 (1984).","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"key":"647_CR30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1586\/14760584.2015.989989","volume":"14","author":"FJ Sanchez-Valdez","year":"2015","unstructured":"Sanchez-Valdez, F. J., Perez Brandan, C., Ferreira, A. & Basombrio, M. A. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease. Expert Rev. Vaccines 14, 681\u2013697 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"647_CR31","doi-asserted-by":"publisher","first-page":"e1418","DOI":"10.1371\/journal.pntd.0001418","volume":"5","author":"C Perez Brandan","year":"2011","unstructured":"Perez Brandan, C., Padilla, A. M., Xu, D., Tarleton, R. L. & Basombrio, M. A. Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge. PLoS Negl. Trop. Dis. 5, e1418 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"647_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4161\/bioe.20680","volume":"3","author":"C Perez Brandan","year":"2012","unstructured":"Perez Brandan, C. & Basombrio, M. A. Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool. Bioengineered 3, 242\u2013246 (2012).","journal-title":"Bioengineered"},{"key":"647_CR33","doi-asserted-by":"publisher","first-page":"e2696","DOI":"10.1371\/journal.pntd.0002696","volume":"8","author":"FJ Sanchez-Valdez","year":"2014","unstructured":"Sanchez-Valdez, F. J. et al. A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge. PLoS Negl. Trop. Dis. 8, e2696 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"647_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1645\/0022-3395(2002)088[0489:TDOTGG]2.0.CO;2","volume":"88","author":"MA Basombrio","year":"2002","unstructured":"Basombrio, M. A. et al. Targeted deletion of the gp72 gene decreases the infectivity of Trypanosoma cruzi for mice and insect vectors. J. Parasitol. 88, 489\u2013493 (2002).","journal-title":"J. Parasitol."},{"key":"647_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-2478(95)02465-4","volume":"48","author":"A Taibi","year":"1995","unstructured":"Taibi, A., Espinoza, A. G. & Ouaissi, A. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas\u2019 disease. Immunol. Lett. 48, 193\u2013200 (1995).","journal-title":"Immunol. Lett."},{"key":"647_CR36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.exppara.2007.05.005","volume":"117","author":"AB Barrio","year":"2007","unstructured":"Barrio, A. B., Van Voorhis, W. C. & Basombrio, M. A. Trypanosoma cruzi: attenuation of virulence and protective immunogenicity after monoallelic disruption of the cub gene. Exp. Parasitol. 117, 382\u2013389 (2007).","journal-title":"Exp. Parasitol."},{"key":"647_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1128\/IAI.00400-07","volume":"76","author":"MP Zago","year":"2008","unstructured":"Zago, M. P. et al. Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi. Infect. Immun. 76, 443\u2013451 (2008).","journal-title":"Infect. Immun."},{"key":"647_CR38","doi-asserted-by":"publisher","first-page":"8772","DOI":"10.1074\/jbc.M112.421057","volume":"288","author":"MM Kulkarni","year":"2013","unstructured":"Kulkarni, M. M. et al. Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivity. J. Biol. Chem. 288, 8772\u20138784 (2013).","journal-title":"J. Biol. Chem."},{"key":"647_CR39","doi-asserted-by":"publisher","first-page":"e22734","DOI":"10.4161\/psb.22734","volume":"8","author":"S Kumari","year":"2013","unstructured":"Kumari, S., Roy, S., Singh, P., Singla-Pareek, S. L. & Pareek, A. Cyclophilins: proteins in search of function. Plant Signal Behav. 8, e22734 (2013).","journal-title":"Plant Signal Behav."},{"key":"647_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/emboj.2011.395","volume":"31","author":"T Iki","year":"2012","unstructured":"Iki, T., Yoshikawa, M., Meshi, T. & Ishikawa, M. Cyclophilin 40 facilitates HSP90-mediated RISC assembly in plants. EMBO J. 31, 267\u2013278 (2012).","journal-title":"EMBO J."},{"key":"647_CR41","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1073\/pnas.0812729106","volume":"106","author":"MR Smith","year":"2009","unstructured":"Smith, M. R. et al. Cyclophilin 40 is required for microRNA activity in Arabidopsis. Proc. Natl Acad. Sci. USA 106, 5424\u20135429 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"647_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0378-1119(02)00559-0","volume":"290","author":"R Pelle","year":"2002","unstructured":"Pelle, R. et al. The African trypanosome cyclophilin A homologue contains unusual conserved central and N-terminal domains and is developmentally regulated. Gene 290, 181\u2013191 (2002).","journal-title":"Gene"},{"key":"647_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.exppara.2014.11.007","volume":"148","author":"JV Rego","year":"2015","unstructured":"Rego, J. V. et al. Molecular characterization of Cyclophilin (TcCyP19) in Trypanosoma cruzi populations susceptible and resistant to benznidazole. Exp. Parasitol. 148, 73\u201380 (2015).","journal-title":"Exp. Parasitol."},{"key":"647_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0378-1097(01)00193-8","volume":"200","author":"J Bua","year":"2001","unstructured":"Bua, J. et al. Characterisation of a cyclophilin isoform in Trypanosoma cruzi. FEMS Microbiol. Lett. 200, 43\u201347 (2001).","journal-title":"FEMS Microbiol. Lett."},{"key":"647_CR45","doi-asserted-by":"publisher","first-page":"e13295","DOI":"10.1111\/cmi.13295","volume":"23","author":"GP Dos Santos","year":"2021","unstructured":"Dos Santos, G. P. et al. Cyclophilin 19 secreted in the host cell cytosol by Trypanosoma cruzi promotes ROS production required for parasite growth. Cell Microbiol. 23, e13295 (2021).","journal-title":"Cell Microbiol."},{"key":"647_CR46","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkp851","volume":"38","author":"M Aslett","year":"2010","unstructured":"Aslett, M. et al. TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Res. 38, D457\u2013D462 (2010).","journal-title":"Nucleic Acids Res."},{"key":"647_CR47","doi-asserted-by":"publisher","unstructured":"Perrone, A. E., Milduberger, N., Fuchs, A. G., Bustos, P. L. & Bua, J. A functional analysis of the cyclophilin repertoire in the protozoan parasite Trypanosoma cruzi. Biomolecules 8, https:\/\/doi.org\/10.3390\/biom8040132 (2018).","DOI":"10.3390\/biom8040132"},{"key":"647_CR48","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.4049\/jimmunol.165.3.1520","volume":"165","author":"RL Tarleton","year":"2000","unstructured":"Tarleton, R. L., Grusby, M. J. & Zhang, L. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. J. Immunol. 165, 1520\u20131525 (2000).","journal-title":"J. Immunol."},{"key":"647_CR49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/imm.12438","volume":"145","author":"MM Kulkarni","year":"2015","unstructured":"Kulkarni, M. M. et al. Signal transducer and activator of transcription 1 (STAT-1) plays a critical role in control of Trypanosoma cruzi infection. Immunology 145, 225\u2013231 (2015).","journal-title":"Immunology"},{"key":"647_CR50","doi-asserted-by":"publisher","unstructured":"Ward, A. I. et al. In vivo analysis of Trypanosoma cruzi persistence foci at single-cell resolution. mBio 11, https:\/\/doi.org\/10.1128\/mBio.01242-20 (2020).","DOI":"10.1128\/mBio.01242-20"},{"key":"647_CR51","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.4049\/jimmunol.128.5.2009","volume":"128","author":"AU Krettli","year":"1982","unstructured":"Krettli, A. U. & Brener, Z. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies. J. Immunol. 128, 2009\u20132012 (1982).","journal-title":"J. Immunol."},{"key":"647_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pt.2007.10.006","volume":"24","author":"P Zaccone","year":"2008","unstructured":"Zaccone, P., Burton, O. T. & Cooke, A. Interplay of parasite-driven immune responses and autoimmunity. Trends Parasitol. 24, 35\u201342 (2008).","journal-title":"Trends Parasitol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00647-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00647-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00647-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T12:08:37Z","timestamp":1682424517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00647-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1038\/s41541-023-00647-5","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"4 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}